Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Published in: Strahlentherapie und Onkologie 10/2012

01-10-2012 | Literatur kommentiert

Indikationen zur neoadjuvanten oder definitiven Radiochemotherapie beim Ösophaguskarzinom auf höchstem Evidenzniveau gesichert

Author: Prof. Dr. M. Guckenberger

Published in: Strahlentherapie und Onkologie | Issue 10/2012

Login to get access

Auszug

Kranzfelder M, Schuster T, Geinitz H et al (2011) Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. Br J Surg 98:768–783 …
Literature
1.
Kranzfelder M, Schuster T, Geinitz H et al (2011) Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. Br J Surg 98:768–783PubMedCrossRef
2.
Sjoquist KM, Burmeister BH, Smithers BM et al (2011) Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 12:681–692PubMedCrossRef
3.
Gebski V, Burmeister B, Smithers BM et al (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226–234PubMedCrossRef
4.
Stahl M, Walz MK, Stuschke M et al (2009) Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851–856PubMedCrossRef
5.
Brundage MD, Davidson JR, Mackillop WJ (1997) Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. J Clin Oncol 15:330–340PubMed
6.
McNeil BJ, Weichselbaum R, Pauker SG (1978) Fallacy of the five-year survival in lung cancer. N Engl J Med 299:1397–1401PubMedCrossRef
Metadata
Title
Indikationen zur neoadjuvanten oder definitiven Radiochemotherapie beim Ösophaguskarzinom auf höchstem Evidenzniveau gesichert
Author
Prof. Dr. M. Guckenberger
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Strahlentherapie und Onkologie / Issue 10/2012
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-012-0213-1

Other articles of this Issue 10/2012

Strahlentherapie und Onkologie 10/2012 Go to the issue

Literatur kommentiert

Sind nichtkrebsdingte Todesursachen durch Suizid, kardiovaskuläre Erkrankung oder Pneumonie bei Patienten mit einem Karzinom der Mundhöhle oder Oropharynx vermeidbar?

Original article

Superiority of conventional intensity-modulated radiotherapy over helical tomotherapy in locally advanced non-small cell lung cancer

Original article

Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer

Original article

Benign painful elbow syndrome

Original article

Do clinicians and patients agree regarding symptoms?

Mitteilungen der Fachgesellschaften

Mitteilungen